This information is for educational purposes only. It is not intended as medical advice. Always consult a qualified healthcare professional.
OTC
HealthdirectFree Australian health advice you can count on.
180 mg/1, Tablet, delayed release
INN: MYCOPHENOLIC ACID
Data updated: 2026-04-25
Available in:
🇬🇧🇯🇵
Form
TABLET, DELAYED RELEASE
Dosage
180 mg/1
Route
ORAL
Storage
—
About This Product
Manufacturer
User Reviews
Reviews reflect personal experiences and are not medical advice. Always consult your doctor.
Archis Pharma LLC
ATC Code
C05BB05
Source
OPENFDA_NDC
(
ARTG
)
Mycophenolic Acid tablets are indicated for the prophylaxis of acute transplant rejection in adult patients receiving allogeneic renal transplants.,Mycophenolic Acid tablets are indicated for induction and maintenance treatment of adult patients with WHO Class III, IV or V lupus nephritis.,This indication is based on the evidence in literature reports of studies of treatment in patients with lupus nephritis, the majority of whom were ISN/RPS (2003) Class IV. The evidence for efficacy was based on surrogate endpoints.
⚠️ Warnings
• Caution should be exercised in patients with history of active peptic ulcer, blood disorders, severe kidney impairment, polyomavirus infections, gastrointestinal disorders.
• Patient may develop with increased risk of certain types of cancer, if it so consult with your doctor immediately.
• Avoid exposure to sunlight/UV light.
• Women taking this medication should seek contraceptive counseling.
